Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

Aug. 5, 2016

Biogen initiates phase I trial of BIIB-068 in healthy subjects

Aug. 2, 2016

EMA accepts for review MAA for sarilumab

Aug. 1, 2016

Merck & Co. discloses BTK inhibitors

Aug. 1, 2016

Merck & Co. announces BTK inhibitors

July 22, 2016

Karos Pharmaceuticals presents tryptophan hydroxylase inhibitors

July 21, 2016

Merck & Co. reports BTK inhibitors

July 21, 2016

Beta1-Integrin is a novel therapeutic target in pathological conditions of the muscle

July 19, 2016

Merck & Co. patents describe BTK inhibitors

July 19, 2016

EMA accepts for review MAA for adalimumab biosimilar SB-5

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...